National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Patent Portfolio Statistics
Profile Summary
This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.
How does the overall patent portfolio of National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government look like?
Total Applications: | 35,070 |
Granted Patents: | 21,775 |
Grant Index | 67.4 % |
Abandoned/Rejected Applications: | 10,534 (32.6%) |
In-Process Applications: | 2,756 |
Average Grant Time: | 3.39 Years |
Average Office Actions: | 2.07 |
Which Technology Area National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government is filing most patents in? (Last 10 years)
Art Unit | Definition | Total Applications |
1644 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 1,204 |
1648 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 1,151 |
1634 | Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry | 1,144 |
1633 | Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry | 1,120 |
1632 | Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry | 1,068 |
How many patents are National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government filing every year?
Year | Total Applications |
2022 | 0* |
2021 | 4* |
2020 | 195 |
2019 | 243 |
2018 | 844 |
*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published
Recently filed patent applications of National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government in USPTO?
Application number: 17/310,432
Abstract:
None
Publication date: –
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Huijun Yin
Publication number: US20220008060A1
Application number: 17/385,230
Abstract:
Publication date: 2022-01-13
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: E Fearnot Neal
Publication number: US20210299239A1
Application number: 17/344,627
Abstract:
Further provided is an anti-cancer agent comprising a CpG oligonucleotide and is characterized in that the CpG oligonucleotide is administered together with an STING agonist. Still further provided is a composition which contains a CpG oligonucleotide and can be used for reducing or eliminating the IgE-inducing activity of an STING agonist.
Publication date: 2021-09-30
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Burcu Temizoz
How are National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government’s applications performing in USPTO?
Application Number | Title | Status | Art Unit | Examiner |
17/310,432 | Aromatic Ring Or Heteroaromatic Ring Compounds, Preparation Method Therefor And Medical Use Thereof | – | – | – |
17/385,230 | Vascular Anchoring Introducer Sheath | – | OPAP | Central, Docket |
17/344,627 | Novel Th1-Inducing Adjuvant Comprising Combination Of Different Nucleic Acid Adjuvants, And Use Of Same | Docketed New Case – Ready for Examination | OPAP | Central, Docket |
17/333,256 | Composition For Prophylaxis Or Treatment Of Il-8 Related Diseases | Docketed New Case – Ready for Examination | OPAP | Central, Docket |